What are your care needs?
From bariatrics to respiratory care, search our site by your clinical area of need.
Where do you work?
From acute care environments to home care, search our site for solutions by workplace.
-
Hillrom Reports Fiscal Third Quarter Financial Results
CHICAGO, Aug. 2, 2019 - Hillrom (NYSE: HRC) today announced financial results for the fiscal third quarter ended June 30, 2019, and provided its fiscal fourth quarter and updated full-year 2019 financial outlook.
Hillrom Announces Acquisition Of Breathe Technologies
CHICAGO, August 2, 2019 - Hillrom (NYSE: HRC) announced today that it has entered into a definitive agreement to acquire Breathe Technologies, Inc., developer and manufacturer of a patented wearable, non-invasive ventilation technology that supports improved patient mobility, for a cash consideration of $130 million.
Hillrom Introduces Next-Generation Breakthrough Technology In Fight Against Diabetic Retinopathy
CHICAGO, July 29, 2019 - Hillrom announced today its latest innovation in vision screening and diagnostics with the introduction of the Welch Allyn® RetinaVue® 700 Imager handheld retinal camera, part of the RetinaVue® Care Delivery Model that enables remote ophthalmologists to diagnose diabetic retinopathy in patients with diabetes during routine primary care office visits. Diabetic retinopathy is the leading cause of blindness in working-age adults1.
Hillrom Declares Fiscal 2019 Fourth Quarter Dividend
CHICAGO, July 16, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), which recently rebranded as Hillrom, announced today that its board of directors declared a fiscal 2019 fourth quarter dividend of $0.21 per share payable on September 30, 2019, to shareholders of record as of the close of business on September 20, 2019. The indicated annual dividend rate is $0.84 per share.
Hillrom Announces Sale Of Surgical Consumable Products
CHICAGO, July 10, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), which recently rebranded as Hillrom, announced today that it has entered into a definitive agreement to sell certain surgical consumable products and related assets to an affiliate of Audax Private Equity ("Audax") for $170 million in cash. The transaction is subject to customary closing conditions and is expected to be completed in Hillrom's fiscal fourth quarter 2019.
